Losartan/hydrochlorothiazide is a combination of two drugs in a single form. It's used to treat high blood pressure. It's also used to reduce the risk of stroke in people with high blood pressure and a heart condition called left ventricular hypertrophy.

The global Losartan and Hydrochlorothiazide Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Losartan and Hydrochlorothiazide Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Losartan and Hydrochlorothiazide Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Losartan and Hydrochlorothiazide Tablets include Alembic, Cadista, Lupin, Rising Pharmaceuticals, Sandoz, Teva, Merck, Torrent and Aurobindo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Losartan and Hydrochlorothiazide Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Losartan and Hydrochlorothiazide Tablets.

Report Scope

The Losartan and Hydrochlorothiazide Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Losartan and Hydrochlorothiazide Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Losartan and Hydrochlorothiazide Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Losartan and Hydrochlorothiazide Tablets Market Report

Report Metric	Details
Report Name	Losartan and Hydrochlorothiazide Tablets Market
Segment by Type	50 mg/ 12.5 mg 100 mg/ 25 mg
Segment by Application	Hospital Clinics Recovery Center
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Alembic, Cadista, Lupin, Rising Pharmaceuticals, Sandoz, Teva, Merck, Torrent, Aurobindo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Losartan and Hydrochlorothiazide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Losartan and Hydrochlorothiazide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Losartan and Hydrochlorothiazide Tablets Market report?

Ans: The main players in the Losartan and Hydrochlorothiazide Tablets Market are Alembic, Cadista, Lupin, Rising Pharmaceuticals, Sandoz, Teva, Merck, Torrent, Aurobindo

What are the Application segmentation covered in the Losartan and Hydrochlorothiazide Tablets Market report?

Ans: The Applications covered in the Losartan and Hydrochlorothiazide Tablets Market report are Hospital, Clinics, Recovery Center

What are the Type segmentation covered in the Losartan and Hydrochlorothiazide Tablets Market report?

Ans: The Types covered in the Losartan and Hydrochlorothiazide Tablets Market report are 50 mg/ 12.5 mg, 100 mg/ 25 mg

1 Losartan and Hydrochlorothiazide Tablets Market Overview

1.1 Product Overview and Scope of Losartan and Hydrochlorothiazide Tablets

1.2 Losartan and Hydrochlorothiazide Tablets Segment by Type

1.2.1 Global Losartan and Hydrochlorothiazide Tablets Market Value Comparison by Type (2024-2030)

1.2.2 50 mg/ 12.5 mg

1.2.3 100 mg/ 25 mg

1.3 Losartan and Hydrochlorothiazide Tablets Segment by Application

1.3.1 Global Losartan and Hydrochlorothiazide Tablets Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Recovery Center

1.4 Global Losartan and Hydrochlorothiazide Tablets Market Size Estimates and Forecasts

1.4.1 Global Losartan and Hydrochlorothiazide Tablets Revenue 2019-2030

1.4.2 Global Losartan and Hydrochlorothiazide Tablets Sales 2019-2030

1.4.3 Global Losartan and Hydrochlorothiazide Tablets Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Losartan and Hydrochlorothiazide Tablets Market Competition by Manufacturers

2.1 Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Manufacturers (2019-2024)

2.2 Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Losartan and Hydrochlorothiazide Tablets Average Price by Manufacturers (2019-2024)

2.4 Global Losartan and Hydrochlorothiazide Tablets Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Losartan and Hydrochlorothiazide Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Losartan and Hydrochlorothiazide Tablets, Product Type & Application

2.7 Losartan and Hydrochlorothiazide Tablets Market Competitive Situation and Trends

2.7.1 Losartan and Hydrochlorothiazide Tablets Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Losartan and Hydrochlorothiazide Tablets Players Market Share by Revenue

2.7.3 Global Losartan and Hydrochlorothiazide Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Losartan and Hydrochlorothiazide Tablets Retrospective Market Scenario by Region

3.1 Global Losartan and Hydrochlorothiazide Tablets Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Losartan and Hydrochlorothiazide Tablets Global Losartan and Hydrochlorothiazide Tablets Sales by Region: 2019-2030

3.2.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Region: 2019-2024

3.2.2 Global Losartan and Hydrochlorothiazide Tablets Sales by Region: 2025-2030

3.3 Global Losartan and Hydrochlorothiazide Tablets Global Losartan and Hydrochlorothiazide Tablets Revenue by Region: 2019-2030

3.3.1 Global Losartan and Hydrochlorothiazide Tablets Revenue by Region: 2019-2024

3.3.2 Global Losartan and Hydrochlorothiazide Tablets Revenue by Region: 2025-2030

3.4 North America Losartan and Hydrochlorothiazide Tablets Market Facts & Figures by Country

3.4.1 North America Losartan and Hydrochlorothiazide Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Losartan and Hydrochlorothiazide Tablets Sales by Country (2019-2030)

3.4.3 North America Losartan and Hydrochlorothiazide Tablets Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Losartan and Hydrochlorothiazide Tablets Market Facts & Figures by Country

3.5.1 Europe Losartan and Hydrochlorothiazide Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Losartan and Hydrochlorothiazide Tablets Sales by Country (2019-2030)

3.5.3 Europe Losartan and Hydrochlorothiazide Tablets Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Losartan and Hydrochlorothiazide Tablets Market Facts & Figures by Country

3.6.1 Asia Pacific Losartan and Hydrochlorothiazide Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales by Country (2019-2030)

3.6.3 Asia Pacific Losartan and Hydrochlorothiazide Tablets Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Losartan and Hydrochlorothiazide Tablets Market Facts & Figures by Country

3.7.1 Latin America Losartan and Hydrochlorothiazide Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Losartan and Hydrochlorothiazide Tablets Sales by Country (2019-2030)

3.7.3 Latin America Losartan and Hydrochlorothiazide Tablets Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Losartan and Hydrochlorothiazide Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Losartan and Hydrochlorothiazide Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Losartan and Hydrochlorothiazide Tablets Sales by Country (2019-2030)

3.8.3 Middle East and Africa Losartan and Hydrochlorothiazide Tablets Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Type (2019-2030)

4.1.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Type (2019-2024)

4.1.2 Global Losartan and Hydrochlorothiazide Tablets Sales by Type (2025-2030)

4.1.3 Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Type (2019-2030)

4.2 Global Losartan and Hydrochlorothiazide Tablets Revenue by Type (2019-2030)

4.2.1 Global Losartan and Hydrochlorothiazide Tablets Revenue by Type (2019-2024)

4.2.2 Global Losartan and Hydrochlorothiazide Tablets Revenue by Type (2025-2030)

4.2.3 Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Type (2019-2030)

4.3 Global Losartan and Hydrochlorothiazide Tablets Price by Type (2019-2030)

5 Segment by Application

5.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Application (2019-2030)

5.1.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Application (2019-2024)

5.1.2 Global Losartan and Hydrochlorothiazide Tablets Sales by Application (2025-2030)

5.1.3 Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Application (2019-2030)

5.2 Global Losartan and Hydrochlorothiazide Tablets Revenue by Application (2019-2030)

5.2.1 Global Losartan and Hydrochlorothiazide Tablets Revenue by Application (2019-2024)

5.2.2 Global Losartan and Hydrochlorothiazide Tablets Revenue by Application (2025-2030)

5.2.3 Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Application (2019-2030)

5.3 Global Losartan and Hydrochlorothiazide Tablets Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Alembic

6.1.1 Alembic Corporation Information

6.1.2 Alembic Description and Business Overview

6.1.3 Alembic Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Alembic Losartan and Hydrochlorothiazide Tablets Product Portfolio

6.1.5 Alembic Recent Developments/Updates

6.2 Cadista

6.2.1 Cadista Corporation Information

6.2.2 Cadista Description and Business Overview

6.2.3 Cadista Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Cadista Losartan and Hydrochlorothiazide Tablets Product Portfolio

6.2.5 Cadista Recent Developments/Updates

6.3 Lupin

6.3.1 Lupin Corporation Information

6.3.2 Lupin Description and Business Overview

6.3.3 Lupin Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Lupin Losartan and Hydrochlorothiazide Tablets Product Portfolio

6.3.5 Lupin Recent Developments/Updates

6.4 Rising Pharmaceuticals

6.4.1 Rising Pharmaceuticals Corporation Information

6.4.2 Rising Pharmaceuticals Description and Business Overview

6.4.3 Rising Pharmaceuticals Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Rising Pharmaceuticals Losartan and Hydrochlorothiazide Tablets Product Portfolio

6.4.5 Rising Pharmaceuticals Recent Developments/Updates

6.5 Sandoz

6.5.1 Sandoz Corporation Information

6.5.2 Sandoz Description and Business Overview

6.5.3 Sandoz Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sandoz Losartan and Hydrochlorothiazide Tablets Product Portfolio

6.5.5 Sandoz Recent Developments/Updates

6.6 Teva

6.6.1 Teva Corporation Information

6.6.2 Teva Description and Business Overview

6.6.3 Teva Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Teva Losartan and Hydrochlorothiazide Tablets Product Portfolio

6.6.5 Teva Recent Developments/Updates

6.7 Merck

6.6.1 Merck Corporation Information

6.6.2 Merck Description and Business Overview

6.6.3 Merck Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck Losartan and Hydrochlorothiazide Tablets Product Portfolio

6.7.5 Merck Recent Developments/Updates

6.8 Torrent

6.8.1 Torrent Corporation Information

6.8.2 Torrent Description and Business Overview

6.8.3 Torrent Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Torrent Losartan and Hydrochlorothiazide Tablets Product Portfolio

6.8.5 Torrent Recent Developments/Updates

6.9 Aurobindo

6.9.1 Aurobindo Corporation Information

6.9.2 Aurobindo Description and Business Overview

6.9.3 Aurobindo Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Aurobindo Losartan and Hydrochlorothiazide Tablets Product Portfolio

6.9.5 Aurobindo Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Losartan and Hydrochlorothiazide Tablets Industry Chain Analysis

7.2 Losartan and Hydrochlorothiazide Tablets Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Losartan and Hydrochlorothiazide Tablets Production Mode & Process

7.4 Losartan and Hydrochlorothiazide Tablets Sales and Marketing

7.4.1 Losartan and Hydrochlorothiazide Tablets Sales Channels

7.4.2 Losartan and Hydrochlorothiazide Tablets Distributors

7.5 Losartan and Hydrochlorothiazide Tablets Customers

8 Losartan and Hydrochlorothiazide Tablets Market Dynamics

8.1 Losartan and Hydrochlorothiazide Tablets Industry Trends

8.2 Losartan and Hydrochlorothiazide Tablets Market Drivers

8.3 Losartan and Hydrochlorothiazide Tablets Market Challenges

8.4 Losartan and Hydrochlorothiazide Tablets Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Alembic

Cadista

Lupin Ltd

Rising Pharmaceuticals

List of Tables

Table 1. Global Losartan and Hydrochlorothiazide Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Losartan and Hydrochlorothiazide Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Losartan and Hydrochlorothiazide Tablets Market Competitive Situation by Manufacturers in 2023

Table 4. Global Losartan and Hydrochlorothiazide Tablets Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Losartan and Hydrochlorothiazide Tablets Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Losartan and Hydrochlorothiazide Tablets Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Losartan and Hydrochlorothiazide Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Losartan and Hydrochlorothiazide Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Losartan and Hydrochlorothiazide Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Losartan and Hydrochlorothiazide Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Losartan and Hydrochlorothiazide Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Losartan and Hydrochlorothiazide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Losartan and Hydrochlorothiazide Tablets as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Losartan and Hydrochlorothiazide Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Losartan and Hydrochlorothiazide Tablets Sales by Region (2019-2024) & (K Units)

Table 18. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Region (2019-2024)

Table 19. Global Losartan and Hydrochlorothiazide Tablets Sales by Region (2025-2030) & (K Units)

Table 20. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Region (2025-2030)

Table 21. Global Losartan and Hydrochlorothiazide Tablets Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Region (2019-2024)

Table 23. Global Losartan and Hydrochlorothiazide Tablets Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Region (2025-2030)

Table 25. North America Losartan and Hydrochlorothiazide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Losartan and Hydrochlorothiazide Tablets Sales by Country (2019-2024) & (K Units)

Table 27. North America Losartan and Hydrochlorothiazide Tablets Sales by Country (2025-2030) & (K Units)

Table 28. North America Losartan and Hydrochlorothiazide Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Losartan and Hydrochlorothiazide Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Losartan and Hydrochlorothiazide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Losartan and Hydrochlorothiazide Tablets Sales by Country (2019-2024) & (K Units)

Table 32. Europe Losartan and Hydrochlorothiazide Tablets Sales by Country (2025-2030) & (K Units)

Table 33. Europe Losartan and Hydrochlorothiazide Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Losartan and Hydrochlorothiazide Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Losartan and Hydrochlorothiazide Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Losartan and Hydrochlorothiazide Tablets Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Losartan and Hydrochlorothiazide Tablets Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Losartan and Hydrochlorothiazide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Losartan and Hydrochlorothiazide Tablets Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Losartan and Hydrochlorothiazide Tablets Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Losartan and Hydrochlorothiazide Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Losartan and Hydrochlorothiazide Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Losartan and Hydrochlorothiazide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Losartan and Hydrochlorothiazide Tablets Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Losartan and Hydrochlorothiazide Tablets Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Losartan and Hydrochlorothiazide Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Losartan and Hydrochlorothiazide Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Losartan and Hydrochlorothiazide Tablets Sales (K Units) by Type (2019-2024)

Table 51. Global Losartan and Hydrochlorothiazide Tablets Sales (K Units) by Type (2025-2030)

Table 52. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Type (2019-2024)

Table 53. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Type (2025-2030)

Table 54. Global Losartan and Hydrochlorothiazide Tablets Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Losartan and Hydrochlorothiazide Tablets Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Type (2019-2024)

Table 57. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Type (2025-2030)

Table 58. Global Losartan and Hydrochlorothiazide Tablets Price (US$/Unit) by Type (2019-2024)

Table 59. Global Losartan and Hydrochlorothiazide Tablets Price (US$/Unit) by Type (2025-2030)

Table 60. Global Losartan and Hydrochlorothiazide Tablets Sales (K Units) by Application (2019-2024)

Table 61. Global Losartan and Hydrochlorothiazide Tablets Sales (K Units) by Application (2025-2030)

Table 62. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Application (2019-2024)

Table 63. Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Application (2025-2030)

Table 64. Global Losartan and Hydrochlorothiazide Tablets Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Losartan and Hydrochlorothiazide Tablets Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Application (2019-2024)

Table 67. Global Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Application (2025-2030)

Table 68. Global Losartan and Hydrochlorothiazide Tablets Price (US$/Unit) by Application (2019-2024)

Table 69. Global Losartan and Hydrochlorothiazide Tablets Price (US$/Unit) by Application (2025-2030)

Table 70. Alembic Corporation Information

Table 71. Alembic Description and Business Overview

Table 72. Alembic Losartan and Hydrochlorothiazide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Alembic Losartan and Hydrochlorothiazide Tablets Product

Table 74. Alembic Recent Developments/Updates

Table 75. Cadista Corporation Information

Table 76. Cadista Description and Business Overview

Table 77. Cadista Losartan and Hydrochlorothiazide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Cadista Losartan and Hydrochlorothiazide Tablets Product

Table 79. Cadista Recent Developments/Updates

Table 80. Lupin Corporation Information

Table 81. Lupin Description and Business Overview

Table 82. Lupin Losartan and Hydrochlorothiazide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Lupin Losartan and Hydrochlorothiazide Tablets Product

Table 84. Lupin Recent Developments/Updates

Table 85. Rising Pharmaceuticals Corporation Information

Table 86. Rising Pharmaceuticals Description and Business Overview

Table 87. Rising Pharmaceuticals Losartan and Hydrochlorothiazide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Rising Pharmaceuticals Losartan and Hydrochlorothiazide Tablets Product

Table 89. Rising Pharmaceuticals Recent Developments/Updates

Table 90. Sandoz Corporation Information

Table 91. Sandoz Description and Business Overview

Table 92. Sandoz Losartan and Hydrochlorothiazide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Sandoz Losartan and Hydrochlorothiazide Tablets Product

Table 94. Sandoz Recent Developments/Updates

Table 95. Teva Corporation Information

Table 96. Teva Description and Business Overview

Table 97. Teva Losartan and Hydrochlorothiazide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Teva Losartan and Hydrochlorothiazide Tablets Product

Table 99. Teva Recent Developments/Updates

Table 100. Merck Corporation Information

Table 101. Merck Description and Business Overview

Table 102. Merck Losartan and Hydrochlorothiazide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Merck Losartan and Hydrochlorothiazide Tablets Product

Table 104. Merck Recent Developments/Updates

Table 105. Torrent Corporation Information

Table 106. Torrent Description and Business Overview

Table 107. Torrent Losartan and Hydrochlorothiazide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Torrent Losartan and Hydrochlorothiazide Tablets Product

Table 109. Torrent Recent Developments/Updates

Table 110. Aurobindo Corporation Information

Table 111. Aurobindo Description and Business Overview

Table 112. Aurobindo Losartan and Hydrochlorothiazide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Aurobindo Losartan and Hydrochlorothiazide Tablets Product

Table 114. Aurobindo Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Losartan and Hydrochlorothiazide Tablets Distributors List

Table 118. Losartan and Hydrochlorothiazide Tablets Customers List

Table 119. Losartan and Hydrochlorothiazide Tablets Market Trends

Table 120. Losartan and Hydrochlorothiazide Tablets Market Drivers

Table 121. Losartan and Hydrochlorothiazide Tablets Market Challenges

Table 122. Losartan and Hydrochlorothiazide Tablets Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Losartan and Hydrochlorothiazide Tablets

Figure 2. Global Losartan and Hydrochlorothiazide Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Losartan and Hydrochlorothiazide Tablets Market Share by Type in 2023 & 2030

Figure 4. 50 mg/ 12.5 mg Product Picture

Figure 5. 100 mg/ 25 mg Product Picture

Figure 6. Global Losartan and Hydrochlorothiazide Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Losartan and Hydrochlorothiazide Tablets Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Clinics

Figure 10. Recovery Center

Figure 11. Global Losartan and Hydrochlorothiazide Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Losartan and Hydrochlorothiazide Tablets Market Size (2019-2030) & (US$ Million)

Figure 13. Global Losartan and Hydrochlorothiazide Tablets Sales (2019-2030) & (K Units)

Figure 14. Global Losartan and Hydrochlorothiazide Tablets Average Price (US$/Unit) & (2019-2030)

Figure 15. Losartan and Hydrochlorothiazide Tablets Report Years Considered

Figure 16. Losartan and Hydrochlorothiazide Tablets Sales Share by Manufacturers in 2023

Figure 17. Global Losartan and Hydrochlorothiazide Tablets Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Losartan and Hydrochlorothiazide Tablets Players: Market Share by Revenue in 2023

Figure 19. Losartan and Hydrochlorothiazide Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Losartan and Hydrochlorothiazide Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Losartan and Hydrochlorothiazide Tablets Sales Market Share by Country (2019-2030)

Figure 22. North America Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Losartan and Hydrochlorothiazide Tablets Sales Market Share by Country (2019-2030)

Figure 26. Europe Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Country (2019-2030)

Figure 27. Germany Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Region (2019-2030)

Figure 34. China Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Losartan and Hydrochlorothiazide Tablets Sales Market Share by Country (2019-2030)

Figure 45. Latin America Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Losartan and Hydrochlorothiazide Tablets Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Losartan and Hydrochlorothiazide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Losartan and Hydrochlorothiazide Tablets by Type (2019-2030)

Figure 55. Global Revenue Market Share of Losartan and Hydrochlorothiazide Tablets by Type (2019-2030)

Figure 56. Global Losartan and Hydrochlorothiazide Tablets Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Losartan and Hydrochlorothiazide Tablets by Application (2019-2030)

Figure 58. Global Revenue Market Share of Losartan and Hydrochlorothiazide Tablets by Application (2019-2030)

Figure 59. Global Losartan and Hydrochlorothiazide Tablets Price (US$/Unit) by Application (2019-2030)

Figure 60. Losartan and Hydrochlorothiazide Tablets Value Chain

Figure 61. Losartan and Hydrochlorothiazide Tablets Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions